Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Biomarkers Orientation Meeting
Research Institute of Fox Chase Cancer Center, Philadelphia, PA, United States
Search grants from Research Institute of Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Do Medicare Claims Measure Chemotherapy Use and Outcomes
Roads to Achieving a Degree in Science
Ship Operations
Eighth and Ninth U.S. Conference On GaAs Manufacturing Technology, May 16-19, 1993 in Atlanta, GA and May 2-5, 1994in Las Vegas, Nevada
Mathematical Sciences: Nonassociative Algebras
Recently added grants:
Training for Research Excellence and MeNtorship in Tuberculosis (TRENT)
Elucidating the therapeutic utility of targeting metabolic dependencies in osteosarcoma
Novel regulators, components and function of endothelial diaphragms
Discovery of small molecules targeting the histone acetylation reader ENL
hiPS cells derived skeletal muscle progenitors and their extracellular vesicles for treatment of sarcopenia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
261201200015I-0-26100001-1
Application #
8556617
Study Section
Project Start
2012-09-20
Project End
2014-09-19
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$4,495
Indirect Cost
Institution
Name
Research Institute of Fox Chase Cancer Center
Department
Type
DUNS #
064367329
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Comments
Be the first to comment on this grant